🔗 Permalink

Inventor profile of:

Mohammad Luqman

City:

Danville, California

Country:

United States

Published Applications:

Last publication date:

2015-06-25

Top Assignees for applications by Mohammad Luqman

The entities that hold a legal rights for patent applications filed by inventor Luqman Mohammad:

NOVARTIS AG 6 Basel, Switzerland
XOMA TECHNOLOGY LTD. 6 Berkeley, CA United States
Novartis Vaccines and Diagnostics, Inc. 5 Emeryville, CA United States
Chiron Corporation 2 Emeryville, CA United States
Chiron Corporation 1 Eneryville, CA United States
Chiron 1 Emeryville, CA United States
Novartis Vaccines & Diagnostics, Inc. 1 Emeryville, CA United States

Recent patent applications by Luqman Mohammad

Mohammad Luqman from Danville, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2015-06-25

US20150175705A1

Chemistry; metallurgy

PRLR-SPECIFIC ANTIBODY AND USES THEREOF

#2 | 2015-03-26

US20150086991A1

Chemistry; metallurgy

USES OF ANTI-CD40 ANTIBODIES

#3 | 2014-07-24

US20140205602A1

Chemistry; metallurgy

ANTAGONIST ANTI-CD40 MONOCLONAL ANTIBODIES AND METHODS FOR THEIR USE

#4 | 2013-09-05

US20130230528A1

Physics

METHODS FOR DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISORDERS MEDIATED BY CD40 SIGNALING

#5 | 2013-01-10

US20130011405A1

Chemistry; metallurgy

Antagonist anti-CD40 monoclonal antibodies and methods for their use

#6 | 2009-08-13

US20090202531A1

Chemistry; metallurgy

USES OF ANTI-CD40 ANTIBODIES

#7 | 2009-05-07

US20090117111A1

Human necessities

Treatment of cancer or pre-malignant conditions using anti-CD40 antibodies

#8 | 2009-02-12

US20090041773A1

Physics

Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject for a CD40-expressing cancer

#9 | 2008-11-06

US20080274118A1

Physics

Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject having an inflammatory or autoimmune disease

#10 | 2008-10-16

US20080254026A1

Chemistry; metallurgy

Antagonist anti-CD40 antibodies

#11 | 2008-03-06

US20080057070A1

Chemistry; metallurgy

Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their Use

#12 | 2007-09-20

US20070218060A1

Chemistry; metallurgy

Use of Antagonist Anti-Cd40 Monoclonal Antibodies for Treatment of Multiple Myeloma

#13 | 2007-05-17

US20070110754A1

Chemistry; metallurgy

Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia

#14 | 2007-05-03

US20070098718A1

Chemistry; metallurgy

Methods of therapy for b cell-related cancers

InventorID:

27063 ⎘